Madrid
All countries
Select a city
Madrid
All countries
Select a city

Best CAR T-cell therapy hematologist-oncologists in Madrid: TOP 1 doctor

Content meets the Bookimed Editorial Policy and is medically reviewed by
Fahad Mawlood - General practitioner. Winner of 4 scientific awards. Served in Western Asia. Former Team Leader of a medical team supporting Arabic-speaking patients. Now responsible for data processing and medical content accuracy.
Lopez Ibor
Pediatric hematologist/oncologist
30 years of experience
Spain, Madrid
Hospital HM Monteprincipe

Lopez Ibor

Pediatric hematologist/oncologist
30 years of experience
  • Dr. López-Ibor specializes in CAR T-cell therapy, an innovative cancer treatment.
  • Utilizes methods like leukapheresis, cell transduction, and in vitro cell expansion.
  • International practice includes the United States, where she trained in Oncology.
  • Directs Pediatric Hematology/Oncology Unit, with expertise in leukemia treatment.
  • Holds a Medicine degree from Complutense University and a Doctorate from the University of Barcelona.
  • Professional memberships in pediatric cancer societies, contributing to her specialization.
  • Conducts online consultations, facilitating access for international patients.
  • Fluent in English and Spanish, ensuring clear communication with diverse patients.
Read more
  • Dr. López-Ibor specializes in CAR T-cell therapy, an innovative cancer treatment.
  • Utilizes methods like leukapheresis, cell transduction, and in vitro cell expansion.
  • International practice includes the United States, where she trained in Oncology.
  • Directs Pediatric Hematology/Oncology Unit, with expertise in leukemia treatment.
  • Holds a Medicine degree from Complutense University and a Doctorate from the University of Barcelona.
  • Professional memberships in pediatric cancer societies, contributing to her specialization.
  • Conducts online consultations, facilitating access for international patients.
  • Fluent in English and Spanish, ensuring clear communication with diverse patients.
Read more